News

Pictured: William Lee, Chris Sander & Nils Weinhold
Beyond the Usual Suspects: Study of Noncoding DNA Reveals New Mutations Linked to Cancer

In a study of patient tumor samples, researchers have found common mutations in parts of the genome that control gene regulation.

Thursday, November 13, 2014
Pictured: Joao Xavier & Eric Pamer
Identification of Beneficial Bacteria May Lead to New Treatment for Common Infection

Clostridium difficile infections are a growing problem, but MSK researchers are looking for innovative ways to prevent and treat them.

Monday, November 10, 2014
Cancer biologist Andrea Ventura
Disorderly DNA: Researchers Simulate a Common Cause of Lung Cancer

For the first time, Memorial Sloan Kettering scientists have created a mouse model that replicates a subtype of non-small cell lung cancer caused by a chromosomal rearrangement — a type of mutation that is common in cancers but thus far has been very difficult to study.

Thursday, November 6, 2014
Pictured: Pseudomonas aeruginosa
The Enemy’s Telltale Mark: Researchers Find Novel Way Body Defends against Harmful Bacteria

MSK researchers discover that the body senses and attacks harmful bacteria indirectly after the pathogens cause stress within the cells.

Tuesday, October 21, 2014
Pictured: Kinisha Gala
Gerstner Sloan Kettering Graduate School Students Receive Fellowships

Annually, GSK awards fellowships to two second-year students and six first-year students based on academic achievement in different elements of the curriculum.

Tuesday, October 14, 2014
DNA wrapped around histones
What Is Epigenetics?

Physician-scientist Omar Abdel-Wahab explains epigenetics, a growing field based on the study of genetic changes that are not part of the DNA code, and how it relates to cancer.

Tuesday, October 14, 2014
Pictured: Ping Chi
Molecular Studies Provide New Clues about Rare Soft Tissue Sarcoma

Genetic analysis reveals biomarkers and possible drug targets for malignant peripheral nerve sheath tumors.

Thursday, October 9, 2014
Pictured: Scott Lowe
Researchers Uncover Potential Target for “Undruggable” Form of Liver Cancer

In taking a new approach to finding treatments for hepatocellular carcinoma, MSK scientists have uncovered a potential drug target for this highly aggressive cancer.

Tuesday, September 30, 2014
Pictured: Experimental Brain Tumor
Genetic “Kill Switch” Could Make Cell Therapies Safer

Researchers have engineered a gene into therapeutic cells that allows them to turn off tumor growth if some of the cells become cancerous.

Thursday, September 18, 2014
Pictured: 2014 SURP Students
Another Successful Summer Undergraduate Research Program Comes to a Close

Learn about the experiences and accomplishments of the 2014 Gerstner Sloan Kettering Summer Undergraduate Research Program students during their ten-week course of study.

Friday, September 12, 2014